According to our latest study, the global Biopharmaceuticals Contract Manufacturing market size was valued at USD 90370 million in 2023 and is forecast to a readjusted size of USD 122970 million by 2030 with a CAGR of 4.5% during review period.
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The publisher report includes an overview of the development of the Biopharmaceuticals Contract Manufacturing industry chain, the market status of Process Development (Biologics, Biosimilars), Packaging (Biologics, Biosimilars), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biopharmaceuticals Contract Manufacturing.
Regionally, the report analyzes the Biopharmaceuticals Contract Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biopharmaceuticals Contract Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biopharmaceuticals Contract Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biopharmaceuticals Contract Manufacturing industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biologics, Biosimilars).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biopharmaceuticals Contract Manufacturing market.
Regional Analysis: The report involves examining the Biopharmaceuticals Contract Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biopharmaceuticals Contract Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biopharmaceuticals Contract Manufacturing:
Company Analysis: Report covers individual Biopharmaceuticals Contract Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biopharmaceuticals Contract Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Process Development, Packaging).
Technology Analysis: Report covers specific technologies relevant to Biopharmaceuticals Contract Manufacturing. It assesses the current state, advancements, and potential future developments in Biopharmaceuticals Contract Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biopharmaceuticals Contract Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Biopharmaceuticals Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Biologics
Biosimilars
麻豆原创 segment by Application
Process Development
Packaging
Others
麻豆原创 segment by players, this report covers
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biopharmaceuticals Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biopharmaceuticals Contract Manufacturing, with revenue, gross margin and global market share of Biopharmaceuticals Contract Manufacturing from 2019 to 2024.
Chapter 3, the Biopharmaceuticals Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biopharmaceuticals Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceuticals Contract Manufacturing.
Chapter 13, to describe Biopharmaceuticals Contract Manufacturing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Biopharmaceuticals Contract Manufacturing
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Biopharmaceuticals Contract Manufacturing by Type
1.3.1 Overview: Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biopharmaceuticals Contract Manufacturing Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Biologics
1.3.4 Biosimilars
1.4 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 by Application
1.4.1 Overview: Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Process Development
1.4.3 Packaging
1.4.4 Others
1.5 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size & Forecast
1.6 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast by Region
1.6.1 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product and Solutions
2.1.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Lonza Group AG
2.2.1 Lonza Group AG Details
2.2.2 Lonza Group AG Major Business
2.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product and Solutions
2.2.4 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Lonza Group AG Recent Developments and Future Plans
2.3 Inno Biologics Sdn Bhd
2.3.1 Inno Biologics Sdn Bhd Details
2.3.2 Inno Biologics Sdn Bhd Major Business
2.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product and Solutions
2.3.4 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Inno Biologics Sdn Bhd Recent Developments and Future Plans
2.4 Rentschler Biopharma
2.4.1 Rentschler Biopharma Details
2.4.2 Rentschler Biopharma Major Business
2.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product and Solutions
2.4.4 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Rentschler Biopharma Recent Developments and Future Plans
2.5 JRS Pharma
2.5.1 JRS Pharma Details
2.5.2 JRS Pharma Major Business
2.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Product and Solutions
2.5.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 JRS Pharma Recent Developments and Future Plans
2.6 AGC Biologics
2.6.1 AGC Biologics Details
2.6.2 AGC Biologics Major Business
2.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
2.6.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 AGC Biologics Recent Developments and Future Plans
2.7 ProBioGen
2.7.1 ProBioGen Details
2.7.2 ProBioGen Major Business
2.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Product and Solutions
2.7.4 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 ProBioGen Recent Developments and Future Plans
2.8 FUJIFILM Diosynth Biotechnologies
2.8.1 FUJIFILM Diosynth Biotechnologies Details
2.8.2 FUJIFILM Diosynth Biotechnologies Major Business
2.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product and Solutions
2.8.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.9 Toyobo Co., Ltd.
2.9.1 Toyobo Co., Ltd. Details
2.9.2 Toyobo Co., Ltd. Major Business
2.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
2.9.4 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Toyobo Co., Ltd. Recent Developments and Future Plans
2.10 Samsung Biologics
2.10.1 Samsung Biologics Details
2.10.2 Samsung Biologics Major Business
2.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
2.10.4 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Samsung Biologics Recent Developments and Future Plans
2.11 Thermo Fisher Scientific
2.11.1 Thermo Fisher Scientific Details
2.11.2 Thermo Fisher Scientific Major Business
2.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product and Solutions
2.11.4 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.12 Binex Co., Ltd.
2.12.1 Binex Co., Ltd. Details
2.12.2 Binex Co., Ltd. Major Business
2.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
2.12.4 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Binex Co., Ltd. Recent Developments and Future Plans
2.13 WuXi Biologics
2.13.1 WuXi Biologics Details
2.13.2 WuXi Biologics Major Business
2.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
2.13.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 WuXi Biologics Recent Developments and Future Plans
2.14 AbbVie, Inc.
2.14.1 AbbVie, Inc. Details
2.14.2 AbbVie, Inc. Major Business
2.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product and Solutions
2.14.4 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 AbbVie, Inc. Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Biopharmaceuticals Contract Manufacturing Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Biopharmaceuticals Contract Manufacturing by Company Revenue
3.2.2 Top 3 Biopharmaceuticals Contract Manufacturing Players 麻豆原创 Share in 2023
3.2.3 Top 6 Biopharmaceuticals Contract Manufacturing Players 麻豆原创 Share in 2023
3.3 Biopharmaceuticals Contract Manufacturing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Biopharmaceuticals Contract Manufacturing 麻豆原创: Region Footprint
3.3.2 Biopharmaceuticals Contract Manufacturing 麻豆原创: Company Product Type Footprint
3.3.3 Biopharmaceuticals Contract Manufacturing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Biopharmaceuticals Contract Manufacturing 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2019-2030)
6.3 North America Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Country
6.3.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Country
7.3.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Country
9.3.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Biopharmaceuticals Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Biopharmaceuticals Contract Manufacturing 麻豆原创 Drivers
11.2 Biopharmaceuticals Contract Manufacturing 麻豆原创 Restraints
11.3 Biopharmaceuticals Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biopharmaceuticals Contract Manufacturing Industry Chain
12.2 Biopharmaceuticals Contract Manufacturing Upstream Analysis
12.3 Biopharmaceuticals Contract Manufacturing Midstream Analysis
12.4 Biopharmaceuticals Contract Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
听
听
*If Applicable.
